Transforming growth factor-β1 in asthmatic airway smooth muscle enlargement: is fibroblast growth factor-2 required?
Y. Bossé,
J. Stankova,
M. Rola-Pleszczynski,
Y. Bossé
The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, Department of Medicine, Respiratory Division, University of British Columbia, Vancouver, BC, Canada
Search for more papers by this authorJ. Stankova
Department of Pediatrics, Immunology Division, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada
Search for more papers by this authorM. Rola-Pleszczynski
Department of Pediatrics, Immunology Division, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada
Search for more papers by this authorY. Bossé,
J. Stankova,
M. Rola-Pleszczynski,
Y. Bossé
The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, Department of Medicine, Respiratory Division, University of British Columbia, Vancouver, BC, Canada
Search for more papers by this authorJ. Stankova
Department of Pediatrics, Immunology Division, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada
Search for more papers by this authorM. Rola-Pleszczynski
Department of Pediatrics, Immunology Division, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, QC, Canada
Search for more papers by this authorCorrespondence:
Dr. Ynuk Bossé, UBC iCAPTURE Centre, St. Paul's hospital, 1081, Burrard St. Room 166, Vancouver BC, Canada V6Z 1Y6. E-mail: [email protected]
Summary
Enlargement of airway smooth muscle (ASM) tissue around the bronchi/bronchioles is a histopathological signature of asthmatic airway remodelling and has been suggested to play a critical role in the increased lung resistance and airway hyperresponsiveness seen in asthmatic patients. The pleiotropic cytokine, TGF-β1, is believed to contribute to several aspects of asthmatic airway remodelling and is known to influence the growth of many cell types. Increased TGF-β1 expression/signalling and ASM growth have been shown to occur concurrently in animal models of asthma. Abundant studies further substantiate this association by showing that therapeutic strategies that reduce or prevent TGF-β1 overexpression/signalling lead to a parallel decrease or prevention of ASM enlargement. Finally, recent findings have supported a direct link of causality between TGF-β1 overexpression/signalling and the overgrowth of ASM tissue. To follow-up on these in vivo studies, many investigators have pursued detailed investigation of ASM in cell culture conditions, assessing the direct role of TGF-β1 on cellular proliferation and/or hypertrophy. Inconsistencies among the in vitro studies suggest that the effect of TGF-β1 on ASM cell proliferation/hypertrophy is contextual. A hypothesis focusing on fibroblast growth factor-2 is presented at the end of this review, which could potentially reconcile the apparent discrepancy between the conflicting in vitro findings with the consistent in vivo finding that TGF-β1 is required for ASM enlargement in asthma.
Cite this as: Y. Bossé, J. Stankova and M. Rola-Pleszczynski, Clinical & Experimental Allergy, 2010 (40) 710–724.
References
- 1 Peters SP. Leukotriene receptor antagonists in asthma therapy. J Allergy Clin Immunol 2003; 111: S62–70.
- 2 Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 2006; 368: 804–13.
- 3 A plea to abandon asthma as a disease concept. Lancet 2006; 368: 705.
- 4 Bosse Y, Pare PD, Seow CY. Airway wall remodeling in asthma: from the epithelial layer to the adventitia. Curr Allergy Asthma Rep 2008; 8: 357–66.
- 5 Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194–200.
- 6 Cockcroft DW. Acquired persistent increase in nonspecific bronchial, reactivity associated with isocyanate exposure. Ann Allergy 1982; 48: 93–5.
- 7 Chan-Yeung M, MacLean L, Paggiaro PL. Follow-up study of 232 patients with occupational asthma caused by western red cedar (Thuja plicata). J Allergy Clin Immunol 1987; 79: 792–6.
- 8 Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984; 39: 131–6.
- 9 Gabbrielli S, Di Lollo S, Stanflin N, Romagnoli P. Myofibroblast and elastic and collagen fiber hyperplasia in the bronchial mucosa: a possible basis for the progressive irreversibility of airway obstruction in chronic asthma. Pathologica 1994; 86: 157–60.
- 10 Lambert RK, Wiggs BR, Kuwano K, Hogg JC, Pare PD. Functional significance of increased airway smooth muscle in asthma and COPD. J Appl Physiol 1993; 74: 2771–81.
- 11 McMillan SJ, Xanthou G, Lloyd CM. Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-{beta} antibody: effect on the Smad signaling pathway. J Immunol 2005; 174: 5774–80.
- 12 Sapienza S, Du T, Eidelman DH, Wang NS, Martin JG. Structural changes in the airways of sensitized brown Norway rats after antigen challenge. Am Rev Respir Dis 1991; 144: 423–7.
- 13 Wang ZL, Walker BA, Weir TD et al. Effect of chronic antigen and beta 2 agonist exposure on airway remodeling in guinea pigs. Am J Respir Crit Care Med 1995; 152: 2097–104.
- 14 Padrid P, Snook S, Finucane T et al. Persistent airway hyperresponsiveness and histologic alterations after chronic antigen challenge in cats. Am J Respir Crit Care Med 1995; 151: 184–93.
- 15 Schelegle ES, Gershwin LJ, Miller LA et al. Allergic asthma induced in rhesus monkeys by house dust mite (Dermatophagoides farinae). Am J Pathol 2001; 158: 333–41.
- 16 Tran MU, Weir AJ, Fanucchi MV et al. Smooth muscle hypertrophy in distal airways of sensitized infant rhesus monkeys exposed to house dust mite allergen. Clin Exp Allergy 2004; 34: 1627–33.
- 17 Herszberg B, Ramos-Barbon D, Tamaoka M, Martin JG, Lavoie JP. Heaves, an asthma-like equine disease, involves airway smooth muscle remodeling. J Allergy Clin Immunol 2006; 118: 382–8.
- 18 Bosse Y, Rola-Pleszczynski M. Controversy surrounding the increased expression of TGF beta 1 in asthma. Respir Res 2007; 8: 66.
- 19 Phipps S, Benyahia F, Ou TT, Barkans J, Robinson DS, Kay AB. Acute allergen-induced airway remodeling in atopic asthma. Am J Respir Cell Mol Biol 2004; 31: 626–32.
- 20 Sagara H, Okada T, Okumura K et al. Activation of TGF-beta/Smad2 signaling is associated with airway remodeling in asthma. J Allergy Clin Immunol 2002; 110: 249–54.
- 21 Torrego A, Hew M, Oates T, Sukkar M, Fan Chung K. Expression and activation of TGF-beta isoforms in acute allergen-induced remodelling in asthma. Thorax 2007; 62: 307–13.
- 22 Rosendahl A, Checchin D, Fehniger TE, Ten Dijke P, Heldin CH, Sideras P. Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation. Am J Respir Cell Mol Biol 2001; 25: 60–8.
- 23 Lee SY, Kim JS, Lee JM et al. Inhaled corticosteroid prevents the thickening of airway smooth muscle in murine model of chronic asthma. Pulm Pharmacol Ther 2008; 21: 14–9.
- 24 Bosse Y, Thompson C, Stankova J, Rola-Pleszczynski M. Fibroblast growth factor 2 and transforming growth factor beta1 synergism in human bronchial smooth muscle cell proliferation. Am J Respir Cell Mol Biol 2006; 34: 746–53.
- 25 Bosse Y, Rola-Pleszczynski M. FGF2 in asthmatic airway-smooth-muscle-cell hyperplasia. Trends Mol Med 2008; 14: 3–11.
- 26 Redington AE, Roche WR, Madden J et al. Basic fibroblast growth factor in asthma: measurement in bronchoalveolar lavage fluid basally and following allergen challenge. J Allergy Clin Immunol 2001; 107: 384–7.
- 27 Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113: 685–700.
- 28 Corbel M, Caulet-Maugendre S, Germain N, Lagente V, Boichot E. Enhancement of gelatinase activity during development of subepithelial fibrosis in a murine model of asthma. Clin Exp Allergy 2003; 33: 696–704.
- 29 McMillan SJ, Lloyd CM. Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy 2004; 34: 497–507.
- 30 Min MG, Song DJ, Miller M et al. Coexposure to environmental tobacco smoke increases levels of allergen-induced airway remodeling in mice. J Immunol 2007; 178: 5321–8.
- 31 Ahn JH, Kim CH, Kim YH et al. Inflammatory and remodeling events in asthma with chronic exposure to house dust mites: a murine model. J Korean Med Sci 2007; 22: 1026–33.
- 32 Cho JY, Miller M, Baek KJ et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 2004; 113: 551–60.
- 33 Cho JY, Miller M, Baek KJ et al. Immunostimulatory DNA inhibits transforming growth factor-beta expression and airway remodeling. Am J Respir Cell Mol Biol 2004; 30: 651–61.
- 34 Youn CJ, Miller M, Baek KJ et al. Immunostimulatory DNA reverses established allergen-induced airway remodeling. J Immunol 2004; 173: 7556–64.
- 35 Brass DM, Savov JD, Whitehead GS, Maxwell AB, Schwartz DA. LPS binding protein is important in the airway response to inhaled endotoxin. J Allergy Clin Immunol 2004; 114: 586–92.
- 36 Kiwamoto T, Ishii Y, Morishima Y et al. Transcription factors T-bet and GATA-3 regulate development of airway remodeling. Am J Respir Crit Care Med 2006; 174: 142–51.
- 37 Lee KS, Park SJ, Kim SR et al. Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor gamma in a murine model of toluene diisocyanate-induced asthma. J Immunol 2006; 177: 5248–57.
- 38 Munitz A, Bachelet I, Levi-Schaffer F. Reversal of airway inflammation and remodeling in asthma by a bispecific antibody fragment linking CCR3 to CD300a. J Allergy Clin Immunol 2006; 118: 1082–9.
- 39 Miller M, Cho JY, McElwain K et al. Corticosteroids prevent myofibroblast accumulation and airway remodeling in mice. Am J Physiol Lung Cell Mol Physiol 2006; 290: L162–9.
- 40
Johnson JR,
Swirski FK,
Gajewska BU et al. Divergent immune responses to house dust mite lead to distinct structural-functional phenotypes.
Am J Physiol Lung Cell Mol Physiol
2007; 293: L730–9.
10.1152/ajplung.00056.2007 Google Scholar
- 41 Yamagata S, Tomita K, Sato R, Niwa A, Higashino H, Tohda Y. Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model. Clin Exp Immunol 2008; 154: 295–304.
- 42 Du Q, Chen Z, Zhou LF, Zhang Q, Huang M, Yin KS. Inhibitory effects of astragaloside IV on ovalbumin-induced chronic experimental asthma. Can J Physiol Pharmacol 2008; 86: 449–57.
- 43 Wang T, Yin KS, Liu KY, Lu GJ, Li YH, Chen JD. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats. Chin Med J (Engl) 2008; 121: 2312–9.
- 44
Song DJ,
Min MG,
Miller M,
Cho JY,
Broide DH.
Environmental tobacco smoke exposure does not prevent corticosteroids reducing inflammation, remodeling, and airway hyperreactivity in mice exposed to allergen.
Am J Physiol Lung Cell Mol Physiol
2009; 297: L380–7.
10.1152/ajplung.90588.2008 Google Scholar
- 45 Lim DH, Cho JY, Song DJ, Lee SY, Miller M, Broide DH. PI3K gamma-deficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling. Am J Physiol Lung Cell Mol Physiol 2009; 296: L210–9.
- 46 Kohan M, Breuer R, Berkman N. Osteopontin induces airway remodeling and lung fibroblast activation in a murine model of asthma. Am J Respir Cell Mol Biol 2009; 41: 290–6.
- 47 Hirota JA, Ask K, Fritz D et al. Role of STAT6 and SMAD2 in a model of chronic allergen exposure: a mouse strain comparison study. Clin Exp Allergy 2009; 39: 147–58.
- 48 Sumi Y, Foley S, Daigle S et al. Structural changes and airway remodelling in occupational asthma at a mean interval of 14 years after cessation of exposure. Clin Exp Allergy 2007; 37: 1781–7.
- 49 Rankin JA, Picarella DE, Geba GP et al. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci USA 1996; 93: 7821–5.
- 50 Lee JJ, McGarry MP, Farmer SC et al. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997; 185: 2143–56.
- 51 Elias JA. Airway remodeling in asthma. Unanswered questions. Am J Respir Crit Care Med 2000; 161: S168–71.
- 52 Zhou L, Dey CR, Wert SE, Whitsett JA. Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-beta 1 chimeric gene. Dev Biol 1996; 175: 227–38.
- 53 Zhu Z, Ma B, Homer RJ, Zheng T, Elias JA. Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J Biol Chem 2001; 276: 25222–9.
- 54 Lee CG, Cho SJ, Kang MJ et al. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J Exp Med 2004; 200: 377–89.
- 55 Leung SY, Niimi A, Noble A et al. Effect of transforming growth factor-beta receptor I kinase inhibitor 2,4-disubstituted pteridine (SD-208) in chronic allergic airway inflammation and remodeling. J Pharmacol Exp Ther 2006; 319: 586–94.
- 56 Le AV, Cho JY, Miller M, McElwain S, Golgotiu K, Broide DH. Inhibition of allergen-induced airway remodeling in Smad 3-deficient mice. J Immunol 2007; 178: 7310–6.
- 57 Fattouh R, Midence NG, Arias K et al. Transforming growth factor-beta regulates house dust mite-induced allergic airway inflammation but not airway remodeling. Am J Respir Crit Care Med 2008; 177: 593–603.
- 58
Alcorn JF,
Rinaldi LM,
Jaffe EF et al. Transforming growth factor-beta1 suppresses airway hyperresponsiveness in allergic airway disease.
Am J Respir Crit Care Med
2007; 176: 974–82.
10.1164/rccm.200702-334OC Google Scholar
- 59 Black PN, Young PG, Skinner SJ. Response of airway smooth muscle cells to TGF-beta 1: effects on growth and synthesis of glycosaminoglycans. Am J Physiol 1996; 271: L910–7.
- 60 Okona-Mensah KB, Shittu E, Page C, Costello J, Kilfeather SA. Inhibition of serum and transforming growth factor beta (TGF-beta1)-induced DNA synthesis in confluent airway smooth muscle by heparin. Br J Pharmacol 1998; 125: 599–606.
- 61 Battegay EJ, Raines EW, Seifert RA, Bowen-Pope DF, Ross R. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990; 63: 515–24.
- 62 Stouffer GA, Owens GK. TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. J Clin Invest 1994; 93: 2048–55.
- 63 Vivien D, Galera P, Lebrun E, Loyau G, Pujol JP. Differential effects of transforming growth factor-beta and epidermal growth factor on the cell cycle of cultured rabbit articular chondrocytes. J Cell Physiol 1990; 143: 534–45.
- 64 Chen G, Khalil N. TGF-beta1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases. Respir Res 2006; 7: 2.
- 65 McKay S, De Jongste JC, Saxena PR, Sharma HS. Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1. Am J Respir Cell Mol Biol 1998; 18: 823–33.
- 66 Goldsmith AM, Bentley JK, Zhou L et al. Transforming growth factor-beta induces airway smooth muscle hypertrophy. Am J Respir Cell Mol Biol 2006; 34: 247–54.
- 67 Heard BE, Hossain S. Hyperplasia of bronchial muscle in asthma. J Pathol 1973; 110: 319–31.
- 68 Johnson PR, Roth M, Tamm M et al. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001; 164: 474–7.
- 69 Woodruff PG, Dolganov GM, Ferrando RE et al. Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med 2004; 169: 1001–6.
- 70 Benayoun L, Druilhe A, Dombret MC, Aubier M, Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 2003; 167: 1360–8.
- 71 Ebina M, Takahashi T, Chiba T, Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis 1993; 148: 720–6.
- 72 Gosens R, Grootte Bromhaar MM, Maarsingh H et al. Bradykinin augments EGF-induced airway smooth muscle proliferation by activation of conventional protein kinase C isoenzymes. Eur J Pharmacol 2006; 535: 253–62.
- 73 Cohen MD, Ciocca V, Panettieri RA Jr TGF-beta 1 modulates human airway smooth-muscle cell proliferation induced by mitogens. Am J Respir Cell Mol Biol 1997; 16: 85–90.
- 74 Krymskaya VP, Hoffman R, Eszterhas A, Ciocca V, Panettieri RA Jr TGF-beta 1 modulates EGF-stimulated phosphatidylinositol 3-kinase activity in human airway smooth muscle cells. Am J Physiol 1997; 273: L1220–7.
- 75 Shin JH, Shim JW, Kim DS, Shim JY. TGF-beta effects on airway smooth muscle cell proliferation, VEGF release and signal transduction pathways. Respirology 2009; 14: 347–53.
- 76
Goldsmith AM,
Hershenson MB,
Wolbert MP,
Bentley JK.
Regulation of airway smooth muscle {alpha}-actin expression by glucocorticoids.
Am J Physiol Lung Cell Mol Physiol
2007; 292: L99–106.
10.1152/ajplung.00269.2006 Google Scholar
- 77 Ediger TL, Toews ML. Synergistic stimulation of airway smooth muscle cell mitogenesis. J Pharmacol Exp Ther 2000; 294: 1076–82.
- 78 Espinosa K, Bosse Y, Stankova J, Rola-Pleszczynski M. CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4. J Allergy Clin Immunol 2003; 111: 1032–40.
- 79 Xie S, Sukkar MB, Issa R, Khorasani NM, Chung KF. Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-{beta}. Am J Physiol Lung Cell Mol Physiol 2007; 293: L245–53.
- 80 Cohen P, Rajah R, Rosenbloom J, Herrick DJ. IGFBP-3 mediates TGF-beta1-induced cell growth in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2000; 278: L545–51.
- 81 Jarai G, Sukkar M, Garrett S et al. Effects of interleukin-1beta, interleukin-13 and transforming growth factor-beta on gene expression in human airway smooth muscle using gene microarrays. Eur J Pharmacol 2004; 497: 255–65.
- 82 Redington AE, Madden J, Frew AJ et al. Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1997; 156: 642–7.
- 83 Aubert JD, Dalal BI, Bai TR, Roberts CR, Hayashi S, Hogg JC. Transforming growth factor beta 1 gene expression in human airways. Thorax 1994; 49: 225–32.
- 84 De Boer WI, Van Schadewijk A, Sont JK et al. Transforming growth factor beta1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1951–7.
- 85 Coker RK, Laurent GJ, Shahzeidi S et al. Diverse cellular TGF-beta 1 and TGF-beta 3 gene expression in normal human and murine lung. Eur Respir J 1996; 9: 2501–7.
- 86 Karagiannidis C, Hense G, Martin C et al. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma. J Allergy Clin Immunol 2006; 117: 111–8.
- 87 Cho SH, Yao Z, Wang SW et al. Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. J Immunol 2003; 170: 4045–52.
- 88 Semitekolou M, Alissafi T, Aggelakopoulou M et al. Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J Exp Med 2009; 206: 1769–85.
- 89 Hardy CL, O'Connor AE, Yao J et al. Follistatin is a candidate endogenous negative regulator of activin A in experimental allergic asthma. Clin Exp Allergy 2006; 36: 941–50.
- 90 Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346: 1699–705.
- 91 Chu HW, Balzar S, Seedorf GJ et al. Transforming growth factor-beta2 induces bronchial epithelial mucin expression in asthma. Am J Pathol 2004; 165: 1097–106.
- 92 Balzar S, Chu HW, Silkoff P et al. Increased TGF-beta2 in severe asthma with eosinophilia. J Allergy Clin Immunol 2005; 115: 110–7.
- 93 Kranenburg AR, De Boer WI, Van Krieken JH et al. Enhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002; 27: 517–25.
- 94 Kranenburg AR, Willems-Widyastuti A, Mooi WJ et al. Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-1. J Pathol 2005; 206: 28–38.
- 95 Schmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23: 479–90.
- 96 Bonner JC, Badgett A, Lindroos PM, Coin PG. Basic fibroblast growth factor induces expression of the PDGF receptor-alpha on human bronchial smooth muscle cells. Am J Physiol 1996; 271: L880–8.
- 97 Lindroos PM, Coin PG, Osornio-Vargas AR, Bonner JC. Interleukin 1 beta (IL-1 beta) and the IL-1 beta-alpha 2-macroglobulin complex upregulate the platelet-derived growth factor alpha-receptor on rat pulmonary fibroblasts. Am J Respir Cell Mol Biol 1995; 13: 455–65.
- 98 Coin PG, Lindroos PM, Bird GS, Osornio-Vargas AR, Roggli VL, Bonner JC. Lipopolysaccharide up-regulates platelet-derived growth factor (PDGF) alpha-receptor expression in rat lung myofibroblasts and enhances response to all PDGF isoforms. J Immunol 1996; 156: 4797–806.
- 99 Tsukamoto T, Matsui T, Nakata H et al. Interleukin-1 enhances the response of osteoblasts to platelet-derived growth factor through the alpha receptor-specific up-regulation. J Biol Chem 1991; 266: 10143–7.
Citing Literature
